Ng George K
CIK 1638744
Transactions on file
10
Open-market buys
10
Win rate (buys)
20%
10 scored
Avg % since filing (buys)
+1.5%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 3,057 | $5.9K | +11.4% | open → |
| 2026-06-16 | 2026-06-15 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,465 | $5.5K | -3.2% | open → |
| 2026-06-01 | 2026-05-29 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,129 | $5.5K | -16.3% | open → |
| 2026-05-19 | 2026-05-15 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 1,843 | $5.5K | -27.6% | open → |
| 2026-05-19 | 2026-04-15 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 1,843 | $5.5K | -27.6% | open → |
| 2026-04-17 | 2026-04-15 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 1,843 | $5.5K | -27.6% | open → |
| 2025-01-29 | 2025-01-27 | PCSA Processa Pharmaceuticals, Inc. | OfficerDirector Chief Executive Officer | Buy | 87,200 | $69.8K | +168.7% | open → |
| 2026-05-01 | 2026-04-30 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,034 | $5.5K | -20.1% | open → |
| 2026-04-30 | 2026-04-15 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 1,843 | $5.5K | -27.6% | open → |
| 2026-04-30 | 2026-03-31 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,136 | $5.4K | -15.2% | open → |
